Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis.

Many microRNAs (miRNAs) exhibit altered expression levels in cancers, and they may be considered as valuable prognostic biomarkers for cancers. Here we aimed to summarize the recent advances in miR-10b involvement in human breast cancer and analyze the predicting role of miR-10b for survival. We searched, Embase, and Wanfang databases to identify studies on the prognostic role of miR-10b expression in breast cancer. A total of 770 patients from 7 eligible studies were included in the analysis. Pooled risk ratios (RRs) with 95% confidence interval (95%CI) were calculated to estimate the effect. Our results showed that high miR-10b expression in patients with breast cancer was significantly associated with poor disease-free survival (DFS) (RR = 1.53; 95%CI = 1.06-2.21; P = 0.02). However, no significant association between miR-10b and overall survival was found in overall studies. Subgroup analysis indicated that high expression of miR-10b was significantly correlated with DFS in Asia (RR = 2.94; 95%CI = 1.71-5.05). The present meta-analysis demonstrated that high expression of miR-10b might predict poor survival in patients with breast cancer. Larger clinical studies are required to further evaluate the role of miR-10b in clinical practice.

[1]  Jyh‐cherng Yu,et al.  The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer , 2014, Journal of Translational Medicine.

[2]  M. Copetti,et al.  Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients , 2014, Molecular Cancer.

[3]  D. Sgroi,et al.  The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials , 2013, Breast Cancer Research.

[4]  Z. Ye,et al.  Clinicopathologic significance of miR-10b expression in gastric carcinoma. , 2013, Human pathology.

[5]  T. Masuda,et al.  Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells. , 2013, International journal of oncology.

[6]  M. Hirokawa,et al.  The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma , 2013, International journal of oncology.

[7]  Bei Zhang,et al.  The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers , 2013, Tumor Biology.

[8]  X. Wang,et al.  Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer , 2012, The Journal of international medical research.

[9]  K. Mimori,et al.  MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells , 2012, Annals of Surgical Oncology.

[10]  K. Ohuchida,et al.  MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. , 2011, Surgery.

[11]  Maria Kafousi,et al.  MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer , 2011, Cell cycle.

[12]  R. Stallings,et al.  MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2 , 2011, Cell Death and Differentiation.

[13]  T. Kondoh,et al.  MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC , 2009, International journal of cancer.

[14]  J. Massagué,et al.  Molecular basis of metastasis. , 2008, The New England journal of medicine.

[15]  Li Ma,et al.  Ma et al. reply , 2008, Nature.

[16]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[17]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[18]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[19]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[20]  G. Yousef,et al.  Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. , 2014, Clinical chemistry.

[21]  W. Chuan.  Correlation of miR-10b with invasiveness and prognosis of breast cancer , 2012 .

[22]  N. Harbeck.  Advances in Breast Cancer Treatment , 2007 .